News & Latest Announcements
The 6 Questions You Must Ask Your Next Oncology CRO Partner
Choosing a Contract Research Organization is one of the most consequential decisions an emerging biotech leader will make. The right partner accelerates your timeline and de-risks…
Read article
Case Study: How a Data-Driven Approach Delivered 25% Faster Enrollment in a Competitive Oncology Trial
What happens when your lead asset is in a head-to-head race with three larger companies for the same, limited pool of patients? For any Head of…
Read article
A Single Source of Truth: Visualizing Data-Driven Site Management
In modern oncology trials, clinical operations leaders are often forced to fly blind. Critical data is scattered across disconnected systems: enrollment numbers in one spreadsheet, site…
Read article
Beyond the Usual Suspects: Why Your Site Selection Strategy is Broken
The oncology landscape presents a strange paradox: the number of available investigator sites has surged by nearly 50% in five years, yet performance has remained flat.…
Read article
Case Study: How an integrated strategy saved a cell therapy trial 18 months and over $50M
What would saving 18 months and over $50 million on your lead asset’s development plan mean for your company? For most emerging biotechs, it’s the difference…
Read article
ICH E6(R3) – A New Operating System for Clinical Trials
The finalization of the ICH E6(R3) Good Clinical Practice (GCP) guideline represents the most significant evolution in clinical trial management in a decade. For sponsors and…
Read article
Why Streamlined Submissions Don’t Guarantee Global Success
The Harmonization Paradox In the world of global oncology trials, a dangerous illusion has taken hold: the harmonization paradox. With the full implementation of the EU’s…
Read article
BIO 2026: Building Connections That Accelerate Development
BIO International Convention in San Diego was, once again, a truly bright event. For four days, professionals from every corner of the life sciences ecosystem came…
Read article
Accelsiors at Swiss Biotech Day 2026: Embracing a Reinvigorated Industry
Swiss Biotech Day once again proved its standing as a central European hub for innovation, bringing together over 3,500 registrants from 58 countries, 150+ exhibitors, 31…
Read article